1.Calleja-Agius, J, Brincat, M. The effect of menopause on the skin and other connective tissues. Gynecol Endocrinol 2012; 28: 273–7.
2.Rachner, TD, Khosla, S, Lorenz, C, Hofbauer, LC. Osteoporosis: now and the future. Lancet 2011; 377: 1276–87.
3.Salari, P, Abdollahi, M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem – actions toward development of new drugs. Int J Pharmacol 2011; 7: 552–67.
4.Clowes, JA, Eghbali-Fatourechi, GZ, McCready, L, Oursler, MJ, Khosla, S, Riggs, BL. Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporosis Int. 2009; 20: 761–9.
5.Brincat, M, Calleja-Agius, J, Vujovic, S, et al. EMAS position statement: bone densitometry screening for osteoporosis. Maturitas 2011; 68: 98–101.
6.Muscat, BY, Brincat, MP, Galea, R, Calleja, N. Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures. Climacteric 2007; 10: 314–19.
7.Dieli-Conwright, CM, Spektor, TM, Rice, JC, Sattler, FR, Schroeder, ET. Hormone replacement therapy and messenger RNA expression of estrogen receptor coregulators after exercise in postmenopausal women. Med Sci Sports Exerc 2010; 42: 422–9.
8.Calleja-Agius, J, Brincat, MP. Hormone replacement therapy post Women's Health Initiative study: where do we stand? Curr Opin Obstet Gynecol 2008; 20: 513–18.
9.Panay, N, Hamoda, H, Arya, R, Savvas, M; British Menopause Society and Women's Health Concern. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int 2013; 19: 59–68.
10.de Villiers, TJ, Gass, ML, Haines, CJ, et al.Global consensus statement on menopausal hormone therapy. Climacteric 2013; 16: 203–4.